Recent Finacing
Recent Raise
InCarda Therapeutics is a clinical-stage biopharmaceutical company developing inhaled formulations of approved cardiovascular drugs, including inhaled flecainide (InRhythm) to rapidly restore normal sinus rhythm in paroxysmal atrial fibrillation.
